Skip to main content

nilutamide

Generic: NILUTAMIDE·Brand: NILANDRON, NILUTAMIDE, Nilandron

nilutamide: 2 clinical trials tracked.

nilutamide evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about nilutamide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence0 indications · 2 study sponsors

Related indications

No linked indication is available.

Clinical Trials (2)

Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel

NCT03070886·Phase 2/Phase 3·CGON
Completed

Primary endpoint: Freedom from progression (FFP) (Phase II)

InterventionalRandomizedopen612 enrolledStarted 2017-04Completion 2025-1050 sites · United StatesNRG Oncology

A Randomized Study of Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone in Patients With Prostate Cancer Who Have PSA Progression After Prostatectomy and/or Radiotherapy

NCT01786265·Phase 2·SPRY
Active, not recruiting

Primary endpoint: Prostate-specific antigen (PSA) free survival (PSA < 0.1 ng/ml)

InterventionalRandomizedopen310 targetStarted 2013-02Completion 2027-021 site · United StatesM.D. Anderson Cancer Center